Josh Brown Explains Selling Pfizer Stock After Long-Term Holding

Decision to Sell Pfizer

• 🎯 Josh Brown, CEO of Ritholtz Wealth Management, explains his decision to sell his position in Pfizer.
• 📉 He acknowledges that Pfizer has been a difficult stock, describing it as one of the worst performers over the last couple of years.
• 💡 Despite an initial purchase price of $28, the stock's underperformance relative to the broader market made it a loss nonetheless.

Rationale and Strategy

• ⚠️ Brown admits to sticking with the stock for no good reason, initially viewing it as a low-risk entry due to how hated and down the stock was.
• 🚀 He was dead wrong about a turnaround and believes the company might only improve now that he's out of the stock.
• 🧩 The primary motivation for selling is opportunity cost, as the stock no longer fits his investment strategy and capital allocation for individual equities.
• ✅ He states he is out of the position, passing the problem to someone else.